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treatment, because it overlapped with work time. She was started 
on fluoxetine 20 mg per day, later titrated up to 40 mg per day. 
Hair pulling and anxiety symptoms improved, but activation 
side effects occurred, mainly insomnia and weight loss. After 4 
weeks of fluoxetine 40 mg per day, quetiapine was introduced, 
beginning with 25 mg bedtime, titrated up to 100 mg in a week. 
Both fluoxetine activation side effects and hair pulling remitted in 
two weeks. Cessation of hair-plucking maintained, at the time of 
reporting, for a period of 4 months. 
To date, studies on trichotillomania treatment using behavioral and 
pharmacological interventions, alone or in combination are equivocal 
with few showing a sustained cessation of hair-plucking. These 
studies suggest that the combination of pharmacological treatment 
and habit reversal therapy (HRT), a cognitive behavioral technique, 
may be more efficacious for the treatment of trichotillomania than 
either approach alone.3 Our report supports the need of further 
investigation of quetiapine, other atypical antipsychotic drugs, and 
their association with selective serotonin reuptake inhibitors in the 
treatment of trichotillomania,4 particularly if therapeutic gains would 
maintain after medication discontinuation, or if additional structured 
psychosocial intervention is required to yield long-term remission.5
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Dear Editor,
Trichotillomania is a poorly understood disorder characterized
by repetitive hair pulling that leads to noticeable hair loss, distress,
and social or functional impairment. It is typically confined to one 
or two sites of the body. It most frequently affects the scalp but 
can also involve eyelashes, eyebrows, pubic hair, body hair, and 
facial hair.1,2
In this report, we describe a case of a patient treated with the 
atypical antipsychotic quetiapine. SRB is a 20-year-old woman, 
who was diagnosed with trichotillomania. She had a history of 
8 years of hair plucking before seeking treatment. On admission, 
she presented anxiety and depressive symptoms, but did not meet 
criteria for either anxiety or mood disorders. Hair pulling worsened 
when she was anxious, but also occurred in other situations, 
especially if she was unfocused. Routine physical examinations 
and investigations were all within normal limits, including 
liver enzymes, except for a bald patch covering approximately 
25% of her back scalp. Although cognitive behavioral therapy
(CBT) consistently shows positive results for the treatment of 
trichotillomania and it is available in our unit, she refused the 
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